Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages.
Abstract
Regulation of gene expression by epigenetic processes is critical for malaria parasite survival in multiple life stages. To evaluate the suitability of targeting these pathways we screened 350 epigenetic inhibitors against asexual blood stages and gametocytes of P. falciparum. We observed [≥]90% inhibition at 10 {micro}M for 28% of compounds, of which a third retained [≥]90% inhibition at 1 {micro}M. These results suggest epigenetic regulation as a promising target for the development of new multi-stage anti-malarials.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multistage activity within a diverse set of epi-drugs against Plasmodium falciparum parasites
N. Coetzee, H. von Gruning, … L.-M. Birkholtz·bioRxiv·Jul 4, 2019
- Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds
M. G. Dans, G. E. Weiss, … P. R. Gilson·bioRxiv·Sep 13, 2019
- A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
S. P. Maher, M. A. Bakowski, … McNama·bioRxiv·Jan 31, 2023
- Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicity
Laura Torres, Matthew E. Fishbaugher, … Gabriel Mitchell·bioRxiv·Oct 26, 2025
- Development of Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors with Negligible Cytotoxicity
J. Almaliti, P. Fajtova, … A. J. O'Donoghue·bioRxiv·Aug 6, 2022
- Screening the Pathogen Box Compounds for Activity Against Plasmodium falciparum Sporozoite Motility
S. kanatani, R. Elahi, … P. Sinnis·bioRxiv·Mar 30, 2022